The page is the record's research on the issuer — no analyst, no rating, no view. # Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Artiva Biotherapeutics, Inc., listed on NASDAQ under ticker ARTV, with ISIN US04317A1079. The LEI is not on the record (no GLEIF record with the exact legal name in jurisdiction US-DE). The security type is Corporate, the segment is not on the record, the sector is 2836 Biological Products, (No Diagnostic Substances), and the jurisdiction is United States, Delaware. The issuer is listed, not halted. ## The disclosure read The record holds 116 filings in the twelve months to 2026-11-08, across 42 filing days. The median gap between filing days is 4 days. The latest filing is dated 2026-11-03, 5 days before the record date, and is of type directors_dealings. The record holds 72 directors_dealings, 23 regulatory_filing, 10 results, 5 director_change, 3 corporate_news, 2 prospectus and 1 agm_egm filing in the window. The NASDAQ exchange median is 52 filings, a cadence gap of 6.0 days, and a latency of 5.0 days, across 4359 issuers. The sector median is 65.5 filings, a cadence gap of 5.5 days, and a latency of 4.0 days, across 176 issuers. ## Auditor The auditor is not on the record (no dei:AuditorName tag on the latest annual report cover (foreign private issuers and older filings carry none)). The auditor's location is not on the record. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change lines. The domicile change is not on the record (EDGAR states no dated change of state of incorporation on a filing line). The segment move is not on the record (the exchanges' tier transfers are not EDGAR filings). The halt flag reads listed, not halted. ## Orderability The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, with the chapter as of 2026-11-04. ## Coverage No research houses were found on the issuer's own investor-relations page. The record holds a count of 0. ## Open research No openly published research notes were found. The record holds a count of 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The sealed years that hold the issuer are 2021, 2022, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. The market's vintage is sealed. ## Sources 7 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001817241.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/ARTV (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/ARTV (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/ARTV · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp